X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31) 31
female (28) 28
male (25) 25
middle aged (22) 22
adult (19) 19
index medicus (17) 17
aged (16) 16
retrospective studies (14) 14
adolescent (11) 11
risk factors (10) 10
cohort studies (8) 8
febrile neutropenia (8) 8
chemotherapy (7) 7
oncology (7) 7
breast-cancer (6) 6
child (6) 6
dose-intensity (6) 6
pegfilgrastim (6) 6
cancer (5) 5
cardiac & cardiovascular systems (5) 5
filgrastim (5) 5
granulocyte colony-stimulating factor - therapeutic use (5) 5
mortality (5) 5
young adult (5) 5
aged, 80 and over (4) 4
antineoplastic agents - adverse effects (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
breast neoplasms - drug therapy (4) 4
colony-stimulating factor (4) 4
double-blind (4) 4
follow-up studies (4) 4
hospitalization (4) 4
hospitalization - statistics & numerical data (4) 4
neoplasms - drug therapy (4) 4
neutropenia - chemically induced (4) 4
pharmacology & pharmacy (4) 4
prognosis (4) 4
survival (4) 4
time factors (4) 4
abridged index medicus (3) 3
animals (3) 3
breast cancer (3) 3
breast neoplasms - pathology (3) 3
child, preschool (3) 3
databases, factual (3) 3
drug therapy (3) 3
drug therapy, combination (3) 3
filgrastim prophylaxis (3) 3
granulocyte colony-stimulating factor (3) 3
health care sciences & services (3) 3
heart transplantation - adverse effects (3) 3
idiopathic pulmonary fibrosis (3) 3
idiopathic pulmonary fibrosis - diagnosis (3) 3
idiopathic pulmonary fibrosis - physiopathology (3) 3
incidence (3) 3
interstitial lung disease (3) 3
medicine & public health (3) 3
multicenter (3) 3
multivariate analysis (3) 3
pediatrics (3) 3
peripheral vascular disease (3) 3
polyethylene glycols (3) 3
prospective studies (3) 3
quality of life (3) 3
reproducibility of results (3) 3
respiratory system (3) 3
risk (3) 3
side effects (3) 3
single-administration pegfilgrastim (3) 3
transplantation (3) 3
treatment outcome (3) 3
united states (3) 3
united-states (3) 3
women (3) 3
amiodarone - therapeutic use (2) 2
analysis (2) 2
angiotensin-converting enzyme inhibitors - pharmacology (2) 2
angiotensin-converting enzyme inhibitors - therapeutic use (2) 2
anti-arrhythmia agents - therapeutic use (2) 2
antihypertensive agents - therapeutic use (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
biopsy (2) 2
blood pressure - drug effects (2) 2
blood pressure - physiology (2) 2
blood-pressure (2) 2
body weight (2) 2
captopril - pharmacology (2) 2
captopril - therapeutic use (2) 2
carbon monoxide (2) 2
cardiac output (2) 2
cardiovascular-disease (2) 2
cell-growth-factors (2) 2
chemotherapy-induced febrile neutropenia - epidemiology (2) 2
chemotherapy-induced febrile neutropenia - etiology (2) 2
chemotherapy-induced febrile neutropenia - prevention & control (2) 2
critical care medicine (2) 2
cyclophosphamide (2) 2
diabetes (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 03/2019, Volume 73, Issue 9, pp. 1293 - 1293
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 10/2018, Volume 113, Issue Supplement, p. S1548
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2009, Volume 31, Issue 5, pp. 1069 - 1081
Journal Article
Journal Article
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 6/2016, Volume 24, Issue 6, pp. 2481 - 2490
Journal Article
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 12/2014, Volume 22, Issue 12, pp. 3275 - 3285
Considerable evidence exists concerning the risk of febrile neutropenia (FN) associated with well-established, older chemotherapy regimens. Little is known,... 
Non-Hodgkin’s lymphoma | Pain Medicine | Chemotherapy | Nursing | Rehabilitation Medicine | Medicine & Public Health | Pancreatic cancer | Oncology | Breast cancer | Nursing Management/Nursing Research | Febrile neutropenia | UNITED-STATES | SOLID TUMORS | ADJUVANT THERAPY | Non-Hodgkin's lymphoma | G-CSF | FILGRASTIM PROPHYLAXIS | HOSPITALIZATION | FEC-D CHEMOTHERAPY | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | NON-HODGKINS-LYMPHOMA | REHABILITATION | DOSE-INTENSITY | OPERABLE BREAST-CANCER | Chemotherapy-Induced Febrile Neutropenia - epidemiology | Risk Assessment | United States | Humans | Middle Aged | Risk Factors | Anti-Infective Agents - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Chemotherapy-Induced Febrile Neutropenia - prevention & control | Hospitalization - statistics & numerical data | Neoplasms - classification | Antineoplastic Agents - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - classification | Granulocyte Colony-Stimulating Factor - therapeutic use | Incidence | Neoplasms - drug therapy | Young Adult | Chemotherapy-Induced Febrile Neutropenia - physiopathology | Female | Aged | Retrospective Studies | Chemotherapy-Induced Febrile Neutropenia - diagnosis | Antineoplastic Agents - classification | Chemoprevention - methods | Anthracyclines | Cyclophosphamide | Anti-infective agents | Lymphomas | Cancer | Neutropenia | Side effects | Fever | Risk factors
Journal Article
Journal Article
Journal Article